Derma Sciences Company Profile (NASDAQ:DSCI)

About Derma Sciences

Derma Sciences logoDerma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: DSCI
  • CUSIP: 24982750
Key Metrics:
  • Previous Close: $4.50
  • 50 Day Moving Average: $4.56
  • 200 Day Moving Average: $4.50
  • 52-Week Range: $2.85 - $5.86
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -40.91
  • P/E Growth: 0.00
  • Market Cap: $127.21M
  • Outstanding Shares: 28,269,000
  • Beta: 0.98
Profitability:
  • Net Margins: -12.32%
  • Return on Equity: -4.09%
  • Return on Assets: -3.22%
Debt:
  • Current Ratio: 1.29%
  • Quick Ratio: 1.02%
Additional Links:
Companies Related to Derma Sciences:

Analyst Ratings

Consensus Ratings for Derma Sciences (NASDAQ:DSCI) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $5.50 (22.22% upside)

Analysts' Ratings History for Derma Sciences (NASDAQ:DSCI)
Show:
DateFirmActionRatingPrice TargetDetails
1/9/2016Oppenheimer Holdings Inc.Reiterated RatingBuyView Rating Details
1/7/2016Canaccord GenuityDowngradeBuy -> Hold$4.00View Rating Details
12/3/2015Roth CapitalBoost Price TargetBuy$9.50 -> $16.00View Rating Details
11/16/2015Piper Jaffray Cos.Lower Price TargetNeutral$6.00 -> $4.00View Rating Details
(Data available from 12/8/2014 forward)

Earnings

Earnings History for Derma Sciences (NASDAQ:DSCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
11/10/2016Q316($0.04)($0.05)$23.90 million$21.80 millionViewListenView Earnings Details
5/11/2016Q116($0.13)($0.07)$20.60 million$20.20 millionViewListenView Earnings Details
3/16/2016Q415($0.39)($0.38)$20.21 million$20.30 millionViewListenView Earnings Details
11/9/2015Q315($0.43)($0.35)$22.31 million$22.20 millionViewListenView Earnings Details
8/10/2015Q215($0.43)($0.36)$21.66 million$22.60 millionViewListenView Earnings Details
5/11/2015Q115($0.46)($0.42)$19.89 million$19.50 millionViewListenView Earnings Details
3/12/2015Q414($0.45)($0.37)$22.90 million$22.90 millionViewListenView Earnings Details
11/10/2014Q314($0.43)($0.45)$21.90 million$20.20 millionViewN/AView Earnings Details
8/7/2014Q2($0.46)($0.34)ViewListenView Earnings Details
5/8/2014Q1($0.32)($0.46)$19.79 million$19.80 millionViewListenView Earnings Details
3/14/2014Q4($0.36)($0.31)$21.26 million$20.70 millionViewListenView Earnings Details
11/13/2013Q3($0.44)($0.29)$21.96 million$22.10 millionViewListenView Earnings Details
8/12/2013Q2 2013($0.45)($0.43)$19.95 million$18.10 millionViewListenView Earnings Details
5/16/2013Q1 2013($0.37)($0.38)$19.00 million$18.80 millionViewListenView Earnings Details
11/12/2012Q312($0.37)($0.24)$19.00 million$19.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Derma Sciences (NASDAQ:DSCI)
Current Year EPS Consensus Estimate: $-0.12 EPS
Next Year EPS Consensus Estimate: $-0.11 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.13)($0.13)($0.13)
Q2 20161($0.08)($0.08)($0.08)
Q3 20161($0.04)($0.04)($0.04)
Q4 20161$0.00$0.00$0.00
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Derma Sciences (NASDAQ:DSCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Derma Sciences (NASDAQ:DSCI)
Insider Ownership Percentage: 9.94%
Institutional Ownership Percentage: 59.12%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/18/2015Srini ConjeevaramDirectorBuy1,100$6.50$7,150.00View SEC Filing  
8/14/2015Samuel E NavarroDirectorBuy10,000$6.51$65,100.00View SEC Filing  
8/13/2015Bruce F WessonDirectorBuy10,000$6.58$65,800.00View SEC Filing  
8/13/2015Edward J QuiltyCEOBuy15,000$6.65$99,750.00View SEC Filing  
8/13/2015Robert C ColeInsiderBuy5,000$6.73$33,650.00View SEC Filing  
6/12/2015Brett HewlettDirectorSell12,000$7.17$86,040.00View SEC Filing  
12/15/2014Srini ConjeevaramDirectorSell12,500$8.49$106,125.00View SEC Filing  
12/4/2014C Richard StaffordDirectorSell6,075$8.59$52,184.25View SEC Filing  
11/25/2014C Richard StaffordDirectorSell1,775$8.26$14,661.50View SEC Filing  
11/18/2014C Richard StaffordDirectorSell3,250$8.59$27,917.50View SEC Filing  
11/17/2014C Richard StaffordDirectorSell1,800$8.50$15,300.00View SEC Filing  
11/14/2014C Richard StaffordDirectorSell5,073$8.48$43,019.04View SEC Filing  
9/16/2014Barry WolfensonInsiderBuy3,750$7.99$29,962.50View SEC Filing  
5/19/2014Barry WolfensonInsiderBuy11,250$8.79$98,887.50View SEC Filing  
5/16/2014Edward QuiltyCEOBuy10,000$8.70$87,000.00View SEC Filing  
1/10/2014Ra Capital Management, LlcInsiderSell300,000$11.83$3,549,000.00View SEC Filing  
9/3/2013C Richard StaffordDirectorSell15,000$14.06$210,900.00View SEC Filing  
9/3/2013John YetterCFOSell12,100$14.16$171,336.00View SEC Filing  
5/30/2013William C MartinMajor ShareholderSell95,568$13.68$1,307,370.24View SEC Filing  
4/29/2013Ra Capital Management, LlcMajor ShareholderBuy3,945$11.40$44,973.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Derma Sciences (NASDAQ:DSCI)
DateHeadline
News IconStock in Focus: Derma Sciences, Inc. (NASDAQ:DSCI) - Liberty News (NASDAQ:DSCI)
libertynewsrecord.com - December 8 at 10:31 PM
News IconInvestor Chatter: Looking at Shares of Derma Sciences, Inc. (NASDAQ:DSCI) - Liberty News (NASDAQ:DSCI)
libertynewsrecord.com - December 6 at 10:02 PM
News IconRelative Strength Index Review on Shares of Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - December 6 at 5:01 PM
News IconTraders are Following Technical Levels for Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - December 3 at 8:13 AM
News IconInvestor Spotlight on Shares of Derma Sciences, Inc. (NASDAQ:DSCI) - OIB News (NASDAQ:DSCI)
oibnews.com - December 2 at 5:06 PM
News IconCompany Review: Narrowing in on Shares of Derma Sciences, Inc. (NASDAQ:DSCI) - Liberty News (NASDAQ:DSCI)
libertynewsrecord.com - December 1 at 10:01 PM
capitalcube.com logoETFs with exposure to Derma Sciences, Inc. : November 30, 2016 (NASDAQ:DSCI)
www.capitalcube.com - November 30 at 4:53 PM
News IconStock Survey: Checking Levels for Derma Sciences, Inc. (NASDAQ:DSCI) - OIB News (NASDAQ:DSCI)
oibnews.com - November 30 at 8:20 AM
News IconInvestors are Looking at Levels for Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 30 at 8:20 AM
capitalcube.com logoDerma Sciences, Inc. :DSCI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016 (NASDAQ:DSCI)
www.capitalcube.com - November 29 at 5:38 PM
News IconDerma Sciences, Inc. DSCI Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:DSCI)
www.bioportfolio.com - November 24 at 4:46 PM
News IconStock Momentum in Focus on Shares of Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 23 at 4:32 PM
News IconValue Composite Score Update on Derma Sciences Inc. (NASDAQ:DSCI) - Wall Street Lion (NASDAQ:DSCI)
wslnews.com - November 22 at 10:16 PM
News IconTechnical Trading Review on Shares of Derma Sciences Inc. (DSCI) - MicroCap Wired (NASDAQ:DSCI)
www.microcapwired.com - November 22 at 10:16 PM
News IconWatching CCI and RSI levels on Derma Sciences Inc. (DSCI) - MicroCap Wired (NASDAQ:DSCI)
www.microcapwired.com - November 17 at 9:50 PM
finance.yahoo.com logoDERMA SCIENCES, INC. Financials (NASDAQ:DSCI)
finance.yahoo.com - November 17 at 4:00 PM
News IconWhat are the Levels Showing for Shares of Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 17 at 7:18 AM
News IconWhat The Charts Are Saying About Derma Sciences Inc. (NASDAQ:DSCI) - Wall Street Lion (NASDAQ:DSCI)
wslnews.com - November 16 at 4:48 PM
News IconFCF Score Review for Derma Sciences Inc. (NASDAQ:DSCI) - Wall Street Lion (NASDAQ:DSCI)
wslnews.com - November 16 at 5:55 AM
News IconMA in Focus for Derma Sciences Inc. (DSCI) - MicroCap Wired (NASDAQ:DSCI)
www.microcapwired.com - November 16 at 5:54 AM
News IconTrading Roundup: Checking Technicals for Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 14 at 10:13 PM
finance.yahoo.com logoEdited Transcript of DSCI earnings conference call or presentation 10-Nov-16 4:00pm GMT (NASDAQ:DSCI)
finance.yahoo.com - November 14 at 4:54 PM
News IconBroker Changes For Derma Sciences, Inc. (DSCI) - NewsDen (NASDAQ:DSCI)
newsden.net - November 12 at 12:04 PM
News IconTechnical Indicator Review on Shares of Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 10 at 8:53 PM
biz.yahoo.com logoDerma Sciences Inc Earnings Call scheduled for 11:00 am ET today (NASDAQ:DSCI)
biz.yahoo.com - November 10 at 8:53 PM
finance.yahoo.com logoDerma Sciences to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum (NASDAQ:DSCI)
finance.yahoo.com - November 10 at 8:53 PM
sg.finance.yahoo.com logoDerma Sciences reports 3Q loss (NASDAQ:DSCI)
sg.finance.yahoo.com - November 10 at 1:18 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:DSCI)
biz.yahoo.com - November 9 at 9:31 PM
News IconTracking Williams %R for Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 7 at 4:31 PM
businesswire.com logoDerma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th - Business Wire (press release) (NASDAQ:DSCI)
www.businesswire.com - November 4 at 9:41 PM
News IconIndicator Level Review for Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 3 at 10:16 PM
News IconTrading Scope: Following Levels on Shares of Derma Sciences Inc. (DSCI) - Yankee Analysts (NASDAQ:DSCI)
yankeeanalysts.com - November 2 at 10:57 PM
News IconDerma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th - Yahoo Sports (NASDAQ:DSCI)
sports.yahoo.com - November 2 at 10:57 PM
publicnow.com logoDerma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th (NASDAQ:DSCI)
www.publicnow.com - November 2 at 4:47 PM
biz.yahoo.com logoDERMA SCIENCES, INC. Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:DSCI)
biz.yahoo.com - October 22 at 8:54 AM
News IconAnalyst Review: Derma Sciences, Inc. (DSCI) - NewsDen (NASDAQ:DSCI)
newsden.net - October 19 at 9:39 AM
News IconForging Higher Over Past 6-Months, Can It Continue For Derma Sciences Inc. (NASDAQ:DSCI) - CSZ News (NASDAQ:DSCI)
cincysportszone.com - October 17 at 4:40 PM
News IconCurrent Price Targets For Derma Sciences, Inc. (DSCI) - NewsDen (NASDAQ:DSCI)
newsden.net - October 6 at 10:15 AM
capitalcube.com logoETF’s with exposure to Derma Sciences, Inc. : October 5, 2016 (NASDAQ:DSCI)
www.capitalcube.com - October 5 at 4:54 PM
News IconWhat do Analysts suggest for: Gilead Sciences Inc. (NASDAQ:GILD) (NASDAQ:DSCI)
myhealthbowl.com - October 4 at 4:36 PM
News IconMead Johnson (MJN) Strong on Overseas Growth & Strategies - Yahoo News (NASDAQ:DSCI)
www.yahoo.com - October 4 at 9:34 AM
zacks.com logoBruker Poised on Buyouts & Innovations amid Several Woes (NASDAQ:DSCI)
www.zacks.com - October 3 at 9:27 AM
investornewswire.com logoDerma Sciences, Inc. (NASDAQ:DSCI) To Hit Price Target Of $8.5? - Investor Newswire (NASDAQ:DSCI)
www.investornewswire.com - October 2 at 9:16 AM
News IconDerma Sciences, Inc. (DSCI) Latest Broker Coverage - NewsDen (NASDAQ:DSCI)
newsden.net - September 29 at 9:41 AM
zacks.com logoHenry Schein (HSIC) Grows Through Acquisitions, Runs Risks (NASDAQ:DSCI)
www.zacks.com - September 26 at 9:25 AM
finance.yahoo.com logoLabCorp: Strong Fundamentals, Sequenom Buyout Raise Hope (NASDAQ:DSCI)
finance.yahoo.com - September 23 at 9:43 AM
finance.yahoo.com logoMedtronic (MDT): Valiant Captivia Data Positive at Three Years (NASDAQ:DSCI)
finance.yahoo.com - September 23 at 9:43 AM
investornewswire.com logoDerma Sciences, Inc. (NASDAQ:DSCI) EPS Estimate At $0 - Investor Newswire (NASDAQ:DSCI)
www.investornewswire.com - September 22 at 4:47 PM
finance.yahoo.com logoDerma Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:DSCI)
finance.yahoo.com - September 21 at 5:12 PM
zacks.com logoAlign Technology: Invisalign Growth Continues Globally (NASDAQ:DSCI)
www.zacks.com - September 21 at 8:59 AM

Social

Derma Sciences (NASDAQ:DSCI) Chart for Thursday, December, 8, 2016


Last Updated on 12/8/2016 by MarketBeat.com Staff